Navigation Links
Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
Date:3/22/2013

ficiencies (PI) are a group of more than 175 disorders in which part of the body's immune system is missing or does not function properly. Normally, the immune system protects the body from pathogenic microorganisms like bacteria, viruses, and fungi, which can cause infectious diseases. When any part of a person's immune system is absent or dysfunctional, they are more likely to become infected and may take longer to recover from infections. When a defect in the immune system is inherited, it is called primary, or inherited, immune deficiency. It is estimated that as many as six million children and adults are affected by PI worldwide.

Secondary immunodeficiencies develop as a result of a variety of conditions such as malignancies, particularly those of the haematopoietic and lymphoreticular systems, metabolic disease and/or malnutrition. Furthermore, burns or severe infection can also cause defective immune function and poor antibody response. In particular, immunoglobulin therapies are used to treat hypogammaglobulinaemia associated with chronic lymphocytic leukaemia (CLL) and multiple myeloma (MM). These patients may benefit from immunoglobulin replacement therapy in addition to standard treatment of their primary disease.

About Baxter International Inc.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with haemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

About Halozyme Therapeutics
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversif
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
2. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
3. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
4. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
5. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Halozyme to Host Third Quarter Financial Results Conference Call
7. Halozyme Reports Second Quarter 2012 Financial Results
8. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
9. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
10. Halozyme Reports First Quarter 2012 Financial Results
11. Halozyme to Host First Quarter 2012 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 KaloBios Pharmaceuticals, Inc. (Nasdaq: ... A. Martell , to the position of Executive Chairman. ... KaloBios Board of Directors. In this new role, he ... to refine and execute on the strategic plan to ... therapeutics for orphan oncology indications with high unmet medical ...
(Date:5/28/2015)... THE WOODLANDS, Texas , May 28, 2015 /PRNewswire/ ... announced today that Lexicon management will present at the ... at 8:00 a.m. Eastern Time in New ... of Lexicon,s clinical development programs and milestones. ... Lexicon,s website at www.lexpharma.com . An archived version ...
(Date:5/28/2015)... SOUTH SAN FRANCISCO, Calif. , May 28, 2015 ... the treatment of cancer, today announced that Sean ... at the upcoming Jefferies 2015 Global Healthcare Conference ... 2:30 p.m. EDT on Tuesday, June 2, 2015. Dr. ... including the company,s Precision cancer immunotherapy and Probody drug ...
Breaking Medicine Technology:KaloBios Appoints Ronald A. Martell Executive Chairman 2KaloBios Appoints Ronald A. Martell Executive Chairman 3KaloBios Appoints Ronald A. Martell Executive Chairman 4KaloBios Appoints Ronald A. Martell Executive Chairman 5Lexicon To Present At The Jefferies 2015 Healthcare Conference 2
... FRANCISCO, July 21, 2011 ClinStar, LLC , ... and Eastern Europe to the pharmaceutical and biotechnology industry, ... speak at Marcus Evans 6th Annual Clinical Research ... FL.    (Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO ) ...
... July 21, 2011 Endologix, Inc. (NASDAQ: ELGX ... today announced financial results for the three and six months ... and Chief Executive Officer, said, "We are pleased with our ... our growth and new product development goals for 2011.  In ...
Cached Medicine Technology:ClinStar to Present on Conducting Clinical Trials in Russia 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 3Endologix Reports 22% Second Quarter 2011 Revenue Growth 4Endologix Reports 22% Second Quarter 2011 Revenue Growth 5Endologix Reports 22% Second Quarter 2011 Revenue Growth 6Endologix Reports 22% Second Quarter 2011 Revenue Growth 7Endologix Reports 22% Second Quarter 2011 Revenue Growth 8Endologix Reports 22% Second Quarter 2011 Revenue Growth 9
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 The Boys ... of $2,500 from Horizon Blue Cross Blue Shield of New ... golfer Natalie Gulbis, the club can receive much more support ... by Acer. , A former Boys & Girls Club member ... in Sacramento, California, Ms. Gulbis has accepted the Horizon Blue ...
(Date:5/28/2015)... Are policies that spell out when Medicare ... financial pain for seniors? That’s what a study published ... set to figure out, and its findings could have ... The study, “Observation Encounters and Subsequent Nursing Facility Stays,” ... how Medicare policies that distinguish between an “inpatient” hospital ...
(Date:5/28/2015)... May 28, 2015 ISMETT , a ... Italy, boosted the Sicilian economy by €132.5 million in expenditure ... benefit of more than €73 million by retaining patients who ... to a new study by the Battelle Memorial Institute. At ... research, training and advanced health care management that is transforming ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Workers’ compensation costs ... typical state, a recent study by the Workers Compensation ... over a three-year period. , The WCRI study, CompScope™ ... which workers missed seven days or more of work with ... the average 2011 Michigan claim was 4 percent lower than ...
(Date:5/28/2015)... Baptist Medical Center Jacksonville has added a ... stroke or other neurological conditions. , The new Center ... in the country and the first in Florida designed ... brain aneurysms. , “Baptist Health is committed to ... are impacted by stroke,” said Nicole Thomas, Baptist Health ...
Breaking Medicine News(10 mins):Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3
... ... inactivating 99.9% of the flu virus. The filter has been treated with Coway,s anti-viral ... ... 2009 -- Coway ,s new anti-flu air filter was recently tested for ...
... The Ensign Group, Inc. (Nasdaq: ENSG ), ... nursing, rehabilitative care services, hospice care and assisted living ... Oppenheimer & Co. 20th Annual Healthcare Conference on November ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , Christopher Christensen, the company,s ...
... Keystone ... and administer health screenings. , ... Philadelphia, Pa. October 27, 2009 – More than 250 West Philadelphia men, ... part of the Health Ministry Program, hosted by Keystone Mercy Health Plan, the largest ...
... ... an Impact as Inaugural President , ... Grand Rapids, Mich. (Vocus) October 29, 2009 -- Sanford-Brown Institute (SBI) - Grand ... first campus president. Amidon comes to SBI - Grand Rapids from Baker College in Muskegon, ...
... Smith & Nephew,s (NYSE: SNN ; LSE: ... first-of-its-kind contribution to the Center for Orthopaedic Trauma Advancement ... Smith & Nephew and COTA entered into a grant ... as an independent, third-party administrator of funds. Smith ...
... autoimmune disease scleroderma can discolor parts of the skin of ... harden their skin, their blood vessels, and their internal organs ... forms, scleroderma gives Dartmouth geneticist Michael Whitfield, his graduate students, ... search for the triggers of the chronic condition. In a ...
Cached Medicine News:Health News:Coway Announces New Anti-Flu Air Filter Can Inactivate 2009 Seasonal Flu Virus 2Health News:The Ensign Group to Present at Oppenheimer 20th Annual Healthcare Conference 2Health News:More Than 250 West Philadelphia Men, Women and Children are Expected to Attend Wellness for Life Event 2Health News:President Selected to Open Sanford-Brown Institute - Grand Rapids 2Health News:Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program 2Health News:Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program 3Health News:Geneticists hunt for scleroderma triggers 2
SPIRAL-FLEX® Oral Precut Reinforced Tubes...
SHERIDAN PREFORMED™ Endotracheal Tubes are designed to conveniently position the anesthesia circuit out of the surgical field for oral and maxillofacial procedures....
Nasal soft cuffed endotracheal tubes designed and constructed especially for long-term nasal intubations....
... is the next step in the ... is an easy to use, easy ... used as a standard tube, as ... quickly and safely handle intubations of ...
Medicine Products: